Investigation on mechanism of antifungal activity of eugenol against Trichophyton rubrum

Medical Mycology

Volumn 51, Issue 5, 2013, Pages 507-513

  De Oliveira Pereira, Fillipe ^a   Mendes, Juliana Moura ^b   De Oliveira Lima, Edeltrudes ^b  

^a FEDERAL UNIVERSITY OF CAMPINA GRANDE   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Antifungal; Dermatophytosis; Ergosterol; Eugenol; Trichophyton rubrum

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL; ERGOSTEROL; EUGENOL; KETOCONAZOLE; SORBITOL;

ANTIFUNGAL ACTIVITY; ARTICLE; CONIDIUM; CONTROLLED STUDY; DERMATOPHYTE; DRUG MECHANISM; DRY WEIGHT; FUNGAL CELL WALL; FUNGAL SPORE GERMINATION; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS HYPHAE; MINIMUM INHIBITORY CONCENTRATION; MORPHOGENESIS; MYCELIAL GROWTH; NONHUMAN; STEROL SYNTHESIS; TRICHOPHYTON RUBRUM;

TRICHOPHYTON RUBRUM;

EID: 84879896180     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2012.742966     Document Type: Article

References (37)

1. Degreef H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia 2008; 166: 257-265.
2. Hern á ndez-Salazar A, Carbajal-Pruneda P, Arenas R. Dermatophytosis due to Trichophyton rubrum. Ten-year period (1996-2006) data collection in a dermatology department in Mexico City. Rev Iberoam Micol 2007; 24: 122-124 [in Spanish].
3. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51: 2-15.
4. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008; 166: 335-352.
5. Godoy-Martinez P, Nunes FG, Yamashita JT, et al. Onychomycosis in S ã o Paulo, Brazil. Mycopathologia 2009; 168: 111-116.
6. Souza LKH, Fernandes OFL, Passos XS, et al. Epidemiological and mycological data of onychomycosis in Goiania, Brazil. Mycoses 2010; 53: 68-71.
7. Loo DS. Systemic antifungal agents: an update of established and new therapies. Adv Dermatol 2006; 22: 101-124.
8. Miceli MH, D í az JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142-151.
9. Oliveira WA, Pereira FO, Luna CGDG, et al. Antifungal activity of Cymbopogon winterianus Jowitt ex Bor against Candida albicans. Braz J Microbiol 2011; 42: 433-441.
10. Kamatou GP, Vermaak I, Viljoen AM. Eugenol - from the remote Maluku Islands to the international market place: a review of a remarkable and versatile molecule. Molecules 2012; 17: 6953-6981.
11. Leem HH, Kim EO, Seo MJ, Choi SW. Anti-oxidant and anti-infl ammatory activities of eugenol and its derivatives from clove (Eugenia caryophyllata Thunb.). J Korean Soc Food Sci Nutr 2011; 40: 1361- 1370.
12. Leite AM, Lima EO, Souza EL, et al. I nhibitory effect of b-pinene, apinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria. Braz J Pharm Sci 2007; 43: 121- 127.
13. Khan MSA, Malik A, Ahmad I. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Med Mycol 2012; 50: 33-42.
14. Yogalakshmi B, Viswanathan P, Anuradha CV. Investigation of antioxidant, anti-infl ammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 2010; 268: 204-212.
15. Santos DA, Barros MES, Hamdan JS. Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton mentagrophytes. J Clin Microbiol 2006; 44: 98-101.
16. Santos DA, Hamdan JS. Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum. J Clin Microbiol 2005; 43: 1917-1920.
17. Sharma N, Tripathi A. Effects of C itrus sinensis (L.) Osbeck epicarp essential oil on growth and morphogenesis of Aspergillus niger (L.) Van Tieghem. Microbiol Res 2006; 163: 337-344.
18. Liu T, Zhang Q, Wang L, et al. The use of global transcriptional analysis to reveal the biological and cellular events involved in distinct development phases of Trichophyton rubrum conidial germination. BMC Genomics 2007; 8: 100-114.
19. Gunji S, Arima K, Beppu T. Screening of antifungal antibiotics according to activities inducing morphological abnormalities. Agric Biol Chem 1983; 47: 2061-2069.
20. Lunde CS, Kubo I. Effect of polygodial on the mitochondrial ATPase of Saccharomyces cereviseae. Antimicrob Agents Chemother 2000; 44: 1943-1953.
21. Escalante A, Gattuso M, P é rez P, Zacchino S. Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Nat Prod 2008; 71: 1720-1725.
22. Arthington-Skaggs BA, Warnock DW, Morrison CJ. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in murine model of invasive candidiasis. Antimicrob Agents Chemother 1999; 44: 2081-2085.
23. Sartoratto A, Machado ALM, Delarmelina C, et al. Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Braz J Microbiol 2004; 35: 275-280.
24. Vermout S, Tabart J, Baldo A, et al. Pathogenesis of dermatophytosis. Mycopathologia 2008; 166: 267-275.
25. Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol 2012; 166: 267-275.
26. Ohara T, Tsuge T. FoSTUA, Encoding a basic helix-loop-helix protein, differentially regulates development of three kinds of asexual spores, macroconidia, microconidia, and chlamydoconidia, in the fungal plant pathogen Fusarium oxysporum. Eukary Cell 2004; 3: 1412-1422.
27. Ghahfarokhi MS, Goodarzi M, Abyaneh MR, Al-Tiraihi T, Seyedipour G. Morphological evidences for onion-induced growth inhibition of Trichophyton rubrum and Trichophyton mentagrophytes. Fitoterapia 2004; 75: 645-655.
28. He M, Du M, Fan M, Bian Z. I n vitro activity of eugenol against Candida albicans biofilms. Mycopathologia 2007; 163: 137-143.
29. Park MJ, Gwa I, Yang KW, et al. Effect of citral, eugenol, nerolidol and terpineol on the ultrastructural changes of Trichophyton mentagrophytes. Fitoterapia 2009; 80: 290-296.
30. Bowman S, Free SJ. The structure and synthesis of the fungal cell wall. Bioassays 2006; 28: 799-808.
31. Frost DJ, Brandt KD, Cugeier D, Goldman R. A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot (Tokyo) 1995; 48: 306-310.
32. Carrasco H, Raimondi M, Svetaz L, et al. Antifungal activity of eugenol analogues: influence of different substituents and studies on mechanism of action. Molecules 2012; 17: 1002-1024.
33. Di Pasqua R, Betts G, Hoskins N, et al. M embrane toxicity of antimicrobial compounds from essential oils. J Agric Food Chem 2007; 55: 4863-4870.
34. Martinez-Rossi NM, Peres NTA, Rossi A. Antifungal resistance mechanisms in dermatophytes. Mycopathologia 2008; 166: 369-383.
35. Ahmad A, Khan A, Manzoor N, Khan LA. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microb Pathol 2010; 48: 35-41.
36. Pinto E, Vale-Silva L, Cavaleiro C, Salgueiro L. Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. J Med Microbiol 2009; 58: 1454-1462.
37. Van Minnebruggen G, Fran ç ois IEJA, Cammue BPA, et al. General overview on past, present and future antimycotics. Open Mycol J 2010; 4: 22-32.